Mixed-backbone oligonucleotides containing phosphorothioate and methylphosphonate linkages as second generation antisense oligonucleotide

被引：7

作者：

Agrawal, S

Jiang, ZW

Zhao, QY

Shaw, D

Sun, D

Saxinger, C

机构：

[1] UNIV ALABAMA,LURLEEN B WALLACE TUMOR INST,BIRMINGHAM,AL 35233

[2] NCI,DIV BASIC SCI,BETHESDA,MD 20892

来源：

NUCLEOSIDES & NUCLEOTIDES | 1997年 / 16卷 / 7-9期

关键词：

D O I：

10.1080/07328319708006109

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Antisense oligonucleotides are being studied as novel therapeutic agents. To further improve the properties of antisense oligonucleotides, we have synthesized phosphorothioate oligonucleotides containing methylphosphonate linkages at the 5'-end, the 3'-end, or in the center, and have evaluated the impact of these linkages on the biophysical properties, biological properties, and some of the safety parameters.

引用

页码：927 / 936

页数：10

共 50 条

[41] Novel antisense oligonucleotides containing hydroxamate linkages: targeted iron-triggered chemical nucleases
Miller, Marvin J.
Li, Hui
Foss, Catherine A.
BIOMETALS, 2009, 22 (03) : 491 - 510
[42] Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity
Liang, Xue-Hai
Shen, Wen
Sun, Hong
Kinberger, Garth A.
Prakash, Thazha P.
Nichols, Joshua G.
Crooke, Stanley T.
NUCLEIC ACIDS RESEARCH, 2016, 44 (08) : 3892 - 3907
[43] Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals
Altmann, KH
Dean, NM
Fabbro, D
Freier, SM
Geiger, T
Haner, R
Husken, D
Martin, P
Monia, BP
Muller, M
Natt, F
Nicklin, P
Phillips, J
Pieles, U
Sasmor, H
Moser, HE
CHIMIA, 1996, 50 (04) : 168 - 176
[44] Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts:: In vivo activity and mechanisms
Wang, SY
Nan, L
Yu, D
Agrawal, S
Zhang, RW
INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (04) : 745 - 752
[45] Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide
Hélène Tran
Michael P. Moazami
Huiya Yang
Diane McKenna-Yasek
Catherine L. Douthwright
Courtney Pinto
Jake Metterville
Minwook Shin
Nitasha Sanil
Craig Dooley
Ajit Puri
Alexandra Weiss
Nicholas Wightman
Heather Gray-Edwards
Miklos Marosfoi
Robert M. King
Thomas Kenderdine
Daniele Fabris
Robert Bowser
Jonathan K. Watts
Robert H. Brown
Nature Medicine, 2022, 28 : 117 - 124
[46] Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide
Tran, Helene
Moazami, Michael P.
Yang, Huiya
McKenna-Yasek, Diane
Douthwright, Catherine L.
Pinto, Courtney
Metterville, Jake
Shin, Minwook
Sanil, Nitasha
Dooley, Craig
Puri, Ajit
Weiss, Alexandra
Wightman, Nicholas
Gray-Edwards, Heather
Marosfoi, Miklos
King, Robert M.
Kenderdine, Thomas
Fabris, Daniele
Bowser, Robert
Watts, Jonathan K.
Brown, Robert H., Jr.
NATURE MEDICINE, 2022, 28 (01) : 117 - +
[47] The effects of mipomersen, a second-generation antisense oligonucleotide, on atherogenic (apoB-containing) lipoproteins in the treatment of homozygous familial hypercholesterolemia
McGowan, Mary P.
Moriarty, Patrick M.
Backes, James M.
CLINICAL LIPIDOLOGY, 2014, 9 (05) : 487 - 503
[48] ANTISENSE PHOSPHOROTHIOATE OLIGONUCLEOTIDES HAVE BOTH SPECIFIC AND NONSPECIFIC EFFECTS ON CELLS CONTAINING HUMAN PAPILLOMAVIRUS TYPE-16
STOREY, A
OATES, D
BANKS, L
CRAWFORD, L
CROOK, T
NUCLEIC ACIDS RESEARCH, 1991, 19 (15) : 4109 - 4114
[49] Properties of mixed backbone oligonucleotides containing 3′-O-methyl ribonucleosides.
Kumar, P
Takaku, H
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) : 2515 - 2520
[50] Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO-PS Backbone for Splice-Switching Applications
Le, Bao T.
Chen, Suxiang
Veedu, Rakesh N.
BIOMOLECULES, 2024, 14 (07)

← 1 2 3 4 5 →